Viatris Inc financial data

Symbol
VTRS on Nasdaq
Industry
Pharmaceutical Preparations
Location
1000 Mylan Boulevard, Canonsburg, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
Upjohn Inc (to 11/10/2020)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 162 % +3.29%
Quick Ratio 49.6 % -9.65%
Operating Margin -0.25 % -103%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.19B shares -0.5%
Entity Public Float 11.9B USD -5.73%
Common Stock, Value, Issued 12.3M USD +0.82%
Weighted Average Number of Shares Outstanding, Basic 1.19B shares -0.66%
Weighted Average Number of Shares Outstanding, Diluted 1.19B shares -1.03%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 15.2B USD -2.33%
Revenue from Contract with Customer, Excluding Assessed Tax 15.2B USD -2.34%
Research and Development Expense 204M USD -2.02%
Operating Income (Loss) -38.8M USD -103%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -640M USD -125%
Income Tax Expense (Benefit) 6.5M USD -99.1%
Earnings Per Share, Basic -0.53 USD/shares -135%
Earnings Per Share, Diluted -0.54 USD/shares -135%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 917M USD +45.8%
Accounts Receivable, after Allowance for Credit Loss, Current 3.57B USD -1.12%
Inventory, Net 3.94B USD +8.26%
Other Assets, Current 270M USD -77.1%
Assets, Current 11.8B USD +20.6%
Deferred Income Tax Assets, Net 685M USD -29.1%
Property, Plant and Equipment, Net 2.66B USD -10.7%
Operating Lease, Right-of-Use Asset 273M USD +9.19%
Intangible Assets, Net (Excluding Goodwill) 18.4B USD -16.6%
Goodwill 9.33B USD -11.5%
Other Assets, Noncurrent 2.45B USD +4%
Assets 45.3B USD -6.91%
Employee-related Liabilities, Current 597M USD -11.2%
Liabilities, Current 7.71B USD +18.2%
Deferred Income Tax Liabilities, Net 1.57B USD -34.6%
Operating Lease, Liability, Noncurrent 192M USD +15%
Other Liabilities, Noncurrent 1.8B USD +7.26%
Liabilities 25.8B USD -7.33%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.98B USD +1.01%
Retained Earnings (Accumulated Deficit) 4.13B USD -23%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 19.5B USD -6.35%
Liabilities and Equity 45.3B USD -6.91%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 615M USD -36.7%
Net Cash Provided by (Used in) Financing Activities -426M USD +56.3%
Net Cash Provided by (Used in) Investing Activities -154M USD +79.4%
Common Stock, Shares Authorized 3B shares 0%
Common Stock, Par or Stated Value Per Share 0.01 EUR/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 22.3M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 919M USD +45.5%
Deferred Tax Assets, Valuation Allowance 421M USD +8.89%
Deferred Tax Assets, Gross 2.16B USD +6.47%
Operating Lease, Liability 248M USD -5.19%
Payments to Acquire Property, Plant, and Equipment 49.8M USD +4.18%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -361M USD -1668%
Lessee, Operating Lease, Liability, to be Paid 271M USD -4.68%
Property, Plant and Equipment, Gross 4.71B USD -6.57%
Operating Lease, Liability, Current 88.4M USD +3.63%
Lessee, Operating Lease, Liability, to be Paid, Year Two 62.7M USD -1.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 79.3M USD +3.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Deferred Income Tax Expense (Benefit) -51.9M USD -94.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 22.3M USD +1.36%
Lessee, Operating Lease, Liability, to be Paid, Year Three 41.5M USD +7.51%
Unrecognized Tax Benefits 273M USD -8.06%
Lessee, Operating Lease, Liability, to be Paid, Year Four 30.4M USD +0.66%
Additional Paid in Capital 18.9B USD +0.72%
Amortization of Intangible Assets 2.32B USD -3.98%
Depreciation, Depletion and Amortization 691M USD -5.34%
Deferred Tax Assets, Net of Valuation Allowance 1.74B USD +5.9%
Interest Expense 567M USD -4.13%